Published by Josh White on 31st March 2025
(Sharecast News) - AstraZeneca announced on Monday that it secured a US regulatory approval and a positive EU recommendation for two of its oncology therapies, Imfinzi and Calquence, marking progress in its immunotherapy and haematology pipelines.
URL: http://www.digitallook.com/dl/news/story/34978526/...